Print
Hydrogen gas, symbolized as H₂, is a unique molecule composed of two hydrogen atoms, each with one proton and one electron.
This molecule’s exceptional feature is its ability to effortlessly traverse cell membranes and the blood-brain barrier, owing to its high lipid solubility and permeability. This unique property allows hydrogen to reach crucial areas within cells, such as the mitochondria and nucleus, making it a potential game-changer in health and cancer treatment.
Potential Health Benefits
Scientists have become increasingly interested in hydrogen’s possible health advantages in recent years. Some studies suggest that hydrogen therapy can help improve lung function in conditions like acute lung injury, asthma, and chronic obstructive pulmonary disease.
It may also decrease brain swelling, offer protection against cell death caused by sepsis-related reactive oxygen species, help reduce liver inflammation triggered by parasites and act as a general shield against oxidative damage. Researchers have also observed that hydrogen may lower blood lactate levels and create a more alkaline environment in the blood, potentially aiding in muscle recovery after strenuous exercise.
Other investigations reveal hydrogen’s ability to lessen the impact of nonalcoholic fatty liver disease, reduce allergic reactions, and even contribute to weight management by fighting obesity and diabetes. A noteworthy phase 2 clinical trial found that hydrogen therapy can be very effective against chronic graft-versus-host disease, which can follow stem cell transplantation.
Over four years, patients who responded to hydrogen therapy had a far higher survival rate than those who did not. Studies also show that hydrogen inhalation can ease radiation-induced bone marrow damage without reducing the ability of treatments to fight tumors. Similarly, hydrogen appears to protect the kidneys from toxic effects caused by certain anti-cancer drugs while preserving those drugs’ effectiveness.
Hydrogen and Cancer
Hydrogen’s potential in cancer therapy often relates to its action as a powerful antioxidant. In cancer treatment, there can be two main approaches to managing reactive oxygen species, commonly called ROS: increasing ROS levels to kill cancer cells (a “pro-oxidant” method) or decreasing ROS levels to stop tumors from thriving (an “antioxidant” method).
Cancer cells already produce large amounts of ROS due to their high activity, which is balanced by internal antioxidant systems. Because they live on this narrow edge, adjusting ROS levels with either pro-oxidant or antioxidant tactics can significantly affect their survival.
Hydrogen belongs to the antioxidant side of this balance. A groundbreaking study published in 2007 showed that hydrogen selectively reduces some of the most harmful oxygen-based molecules, suggesting it works as a targeted antioxidant. Reducing specific ROS helps disrupt growth signals in cancer cells and slows down their ability to spread. For instance, ROS can boost the activity of enzymes that break down barriers around tumors, allowing them to invade new areas. By lowering ROS, hydrogen may help block this chain of events and act as a barrier against tumor progression.
Why Lowering ROS Can Be Helpful
High levels of ROS can activate specific enzymes that allow tumors to break down the protective layers around them. One such enzyme, plasmin, helps degrade the tumor’s extracellular matrix, making it easier for cancer to grow and spread.
By neutralizing ROS, hydrogen may limit the production of plasmin. This effect appears similar to some researchers’ approach with drugs like amiloride, which block plasmin formation and hinder tumor invasion. In this sense, hydrogen could be seen as part of a broader antioxidant strategy aiming to “lock” tumors in place and discourage further spread.
Finding the Right Balance
The use of antioxidants and pro-oxidants in cancer treatment is a complex matter. If not used at the right levels, they could inadvertently aid the tumor’s adaptation. This complexity underscores the importance of developing a clear strategy that focuses on either pro-oxidant or antioxidant methods, rather than randomly combining them.
This is particularly crucial in treatments like chemotherapy, which increases ROS in cancer cells to destroy them. In such cases, hydrogen might be more suitable in phases when the strategy shifts to long-term defense, helping the body recover while preventing tumors from regaining their footing.
Antioxidant Power in Action
Hydrogen’s anti-cancer capabilities have been tested in different cancer types, including lung, gastric, endometrial, and gallbladder cancer, as well as fibrosarcoma and glioblastoma. One of the earliest experiments, in a mouse model of skin carcinoma, indicated that hydrogen therapy could cause tumors to turn black, shrink at the base, or even fall off.
Later research confirmed that hydrogen indeed neutralizes some of the most potent and damaging ROS, backing up those earlier observations. Additional studies suggest that hydrogen can also spark changes in cell metabolism and boost the expression of Nrf2, a protein that regulates antioxidant genes.
Looking Ahead
The evidence so far points to hydrogen as a promising ally in disease prevention and cancer therapy. Its ability to cross biological barriers, lower dangerous ROS, and protect healthy tissue during treatments makes it an intriguing candidate for further research.
Although more clinical trials are needed, hydrogen stands out as a unique, powerful antioxidant that could one day change the way we approach health challenges, ranging from inflammatory conditions to advanced cancers.
